This Article Full Text Full Text (PDF) All Versions of this Article: 35/5/1192    most recent 01.STR.0000125722.10606.07v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kagiyama, T. Articles by Martynyuk, A. E. Search for Related Content PubMed PubMed Citation Articles by Kagiyama, T. Articles by Martynyuk, A. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-PHENYLALANINE L-TYROSINE Medline Plus Health Information Stroke Related Collections Neuroprotectors Other Stroke Animal models of human disease Acute Cerebral Infarction

(Stroke. 2004;35:1192.)
© 2004 American Heart Association, Inc.

Original Contributions

Neuroprotective Action of Halogenated Derivatives of L-Phenylalanine

Tomoko Kagiyama, MD; Alexander V. Glushakov, PhD; Colin Sumners, PhD; Brandy Roose, MPH; Donn M. Dennis, MD; M. Ian Phillips, PhD, DSc; Mehmet S. Ozcan, MD; Christoph N. Seubert, MD, PhD Anatoly E. Martynyuk, PhD, DSc

From the Departments of Anesthesiology (A.V.G., D.M.D., M.O., C.N.S., A.E.M.), Neuroscience (C.S., A.E.M.), and Physiology and Functional Genomics (T.K., C.S., B.R., M.I.P.), University of Florida, Gainesville, Fla.

Correspondence Anatoly E. Martynyuk, PhD, Department of Anesthesiology, University of Florida, PO Box 100254, JHMHC, 1600 SW Archer Road, Gainesville, FL 32610-0254. E-mail AMartynyuk{at}anest.ufl.edu

Background and Purpose— The aromatic amino acid L-Phenylalanine (L-Phe) significantly and reversibly depresses excitatory glutamatergic synaptic transmission (GST) via a unique set of presynaptic and postsynaptic mechanisms. Therefore, we hypothesized that endogenous derivatives of L-Phe, which display potent antiglutamatergic activity, may safely and efficaciously protect the brain during conditions characterized by overactivation of glutamate receptors.

Methods— We tested this hypothesis in vitro with a combination of patch-clamp and lactate dehydrogenase (LDH) analyses in rat cultured neurons exposed to simulated ischemia, and in vivo using a rat model of experimental stroke caused by transient middle cerebral artery occlusion (MCAO).

Results— 3,5-diiodo-L-tyrosine (DIT) and 3,5-dibromo-L-tyrosine (DBrT), endogenous halogenated derivatives of L-Phe, attenuated GST by similar mechanisms as L-Phe, but with greater potency. For example, the IC₅₀s for DIT and DBrT to depress the frequency of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptor-mediated mEPSCs were 104.6±14.1 µmol/L and 127.5±13.3 µmol/L, respectively. Depression of GST by DIT and DBrT persisted during energy deprivation. Furthermore, DBrT significantly reduced LDH release in neuronal cultures exposed to oxygen glucose deprivation. In rats subjected to transient MCAO, DBrT decreased the brain infarct volume and neurological deficit score to 52.7±14.1% and 57.1±12.0% of control values, respectively. DBrT neither altered atrioventricular nodal and intraventricular conduction in isolated heart, nor heart rate and blood pressure in vivo.

Conclusions— DBrT, an endogenous halogenated derivative of L-Phe, shows promise as a representative of a novel class of neuroprotective agents by exerting significant neuroprotection in both in vitro and in vivo models of brain ischemia.

Key Words: excitotoxicity • neuroprotection • receptors, glutamate • stroke

This article has been cited by other articles:

				V. Yarotskyy, A. V. Glushakov, C. Sumners, N. Gravenstein, D. M. Dennis, C. N. Seubert, and A. E. Martynyuk Differential Modulation of Glutamatergic Transmission by 3,5-Dibromo-L-phenylalanine Mol. Pharmacol., May 1, 2005; 67(5): 1648 - 1654. [Abstract] [Full Text] [PDF]